• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom launches G6 mobile app in Spanish

July 27, 2022 By Sean Whooley

Dexcom G6 spanish mobile app
Dexcom G6 user Julie shows the new Dexcom G6 mobile app in Spanish. [Image from Dexcom]
Dexcom (Nasdaq:DXCM) announced today that it launched its G6 continuous glucose monitor (CGM) mobile app in Spanish.

San Diego-based Dexcom’s G6 mobile app in Spanish has been made available immediately for users with a compatible iOS (v1.10.1) or Android (v1.10.0) smart device.

The company said in a news release that diabetes disproportionately impacts Latinos. As of 2022, it is estimated that 11.8% of U.S. Latino adults have diagnosed diabetes, according to Diabetes.org. The CDC estimates that U.S. Latino adults have more than a 50% chance of developing type 2 diabetes, with a greater risk of complications.

“With a myriad of studies that point to language barriers in healthcare leading to miscommunication between patients and healthcare providers and a decrease in quality of care and patient safety, it’s important to provide access to diabetes information in a patient’s preferred language to improve health outcomes,” said Ana-Mari Calleja Carr, district business manager at Dexcom representing the South Florida region. “Launching the Dexcom G6 app in Spanish is a positive step toward improving health equity for individuals with diabetes who primarily speak Spanish.”

Users can install the latest version of their app and set their compatible smartphone language to Spanish (any dialect/region) to access the G6 mobile app in Spanish. The app will automatically display in Spanish as long as the phone language is set to Spanish.

“Being able to offer this powerful CGM technology to my Spanish-speaking patients in their preferred language can help them better understand their diabetes and be more proactive about managing their health,” said Dr. Rocio Harbison, an endocrinologist who treats a large Spanish-speaking population. “CGM technology is one of the most powerful tools available for managing diabetes and this new development from Dexcom will help improve access for Spanish-speaking people who often have to navigate their health with limited Spanish-language tools.”

Dexcom’s G6, its current-generation CGM device, uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a compatible smart device or receiver. It provides real-time glucose data, eliminating the need for fingersticks while also offering customizable alerts and alarms to help avoid potentially dangerous low and high blood sugar events.

The company said its Dexcom Follow app — an app that allows up to 10 people follow a user’s glucose data — is not immediately available in Spanish but the functionality will be added in a future product update.

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS